November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has comparable ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary ...
November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...
November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...
November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 11, 2011 — Maquet Cardiovascular announced U.S. Food and Drug Administration (FDA) 510(k) clearance and CE mark ...
November 10, 2011 – GE Healthcare will feature several new products and solutions at the Cardiovascular Research ...
November 9, 2011 — InfraReDx Inc. announced the launch of its TVC Imaging System, an enhanced version of the LipiScan ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
November 9, 2011 — Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute drug-eluting ...
November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 9, 2011 — Volcano Corp. announced results from the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluatio ...
November 15, 2011